UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agencyThe announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.{}

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.https://www.cnbc.com/2026/06/17/huntingtons-disease-drugmaker-uniqure-to-seek-fda-ok-for-gene-therapy.html